Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-24-000158

Director sold 7,073 shares at $448.00 ($3,168,704)

  • Director acquired 7,073 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

SACHS BRUCE I · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-05-22 Exercise or conversion : show line 1 in the form 10b5-1 +7,073 $93.51 $661,396 47,073 D
2024-05-22 Sale : show line 2 in the form 10b5-1 −7,073 $448.00 $3,168,704 40,000 D
Open-market sales · 7,073 sh · avg $448.00 · $3,168,704

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2024-05-22 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −7,073 $93.51 2026-05-31 7,073 0 D
Loading xslF345X05/wk-form4_1716581569.xml…